OYAGEN is a biotechnology company formed on September 5, 2003, for the purpose of discovering, developing, and commercializing novel pharmaceutical therapies that seek to exploit RNA editing and DNA editing enzymes. OyaGen holds exclusive rights to important technologies originating from the…
Finance: Commercial Banking, Lending, Underwriting
No mentions listed yet.
No one has curated this page yet. Be the first.
Curate